| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $120,294 ) |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 5 | 12/22/2023 | NON-COMPETING CONTINUATION | $120,294 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $120,294 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 4 | 1/13/2023 | NON-COMPETING CONTINUATION | $120,294 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $120,294 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 3 | 12/31/2021 | NON-COMPETING CONTINUATION | $120,294 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $120,294 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 2 | 3/3/2021 | NON-COMPETING CONTINUATION | $120,294 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $120,294 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 1 | 12/15/2019 | NEW | $120,294 |
|
|